Combinations of second-line drugs for rheumatoid arthritis: is remission induction a reasonable goal?
Le Loët
X
X
Vittecoq
O
O
Daragon
A
A
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D012074:Remission Induction
D018501:Antirheumatic Agents